EAACI Congress 2024

31 May - 03 June 2024 Valencia, Spain

FT 22 - Flash talks on AllergoOncology

Sunday 02 Jun, 16:45 PM - 18:15 PM Valencia, Spain
Cordoba Flash Talks
16:45 001389
AllergoOncology: Application of the basophil activation test (BAT) in pre-clinical testing and the first-in-class clinical trial of anti-cancer IgE immunotherapy
16:52 001961
IgE induces hyperinflammatory repolarisation of ovarian cancer patient macrophages to restrict an immunosuppressive macrophage:Treg interaction
16:59 002032
AllergoOncology: B cell phenotype and immunoglobulin isotype predict immune related adverse events and response to checkpoint inhibitor therapy in advanced melanoma
17:06 001274
Pan-Cancer Analysis of Mast Cell Activation
17:13 002003
AllergoOncology: Anti-tumoral activity of anti-HER2 IgE against high and medium/low HER2-expressing breast cancer
17:20 002047
Skin microbiome dynamics as predictor and pathogenesis mechanism for severe radiodermatitis in breast cancer patients
17:27 000216
A dual-reporter mouse model (IFN-γ/IL-4) for simultaneous in vivo screening of Th1/Th2 populations initiated by allergenic pollen extracts
17:34 002017
Successful rapid drug desensitization with adrenaline infusion pump in severe allergic reactions
17:41 001424
Hypersensitivity Reactions to Oxaliplatin and Carboplatin: Clinical Features and Cross Reactivity
17:48 100351
Decoding allergic patient's monocytic cells and their value in AllergoOncology with MacTooL: an EAACI scoping review